Latest Rome process Stories

IBS, abdominal pain more common in nurses working rotating shiftsNurses participating in shift work, especially those working rotating shifts, face a significantly increased risk of developing Irritable Bowel Syndrome (IBS) and abdominal pain compared to those working a standard day-time schedule, according to research published in the American Journal of Gastroenterology."We know that people participating in shift work often complain of gastrointestinal symptoms such as abdominal pain,...

Irritable bowel syndrome (IBS) is a common gastrointestinal functional disorder that can greatly affect the patient's well being. Multiple interacting mechanisms, including alterations in the intestinal microbiota, are suspected to lie behind IBS aetiology.A research article to be published on December 21, 2009 in the World Journal of Gastroenterology addresses this question. The research team from Finland quantified fourteen bacterial phylotypes which corresponded with bacterial species of...

IBS remains a common intestinal disorder causing significant discomfort and poor quality of life in patients who have the diagnosis. TCAs have been shown to improve abdominal pain in patients with IBS; however, there is insufficient evidence of global symptom relief. The search for an optimal treatment to improve symptoms and quality of life in IBS remains ongoing.A research article to be published on August 7, 2009 in the World Journal of Gastroenterology addresses this question. In the...

Although visceral hypersensitivity is considered a hallmark feature of IBS, conflicting evidence exists regarding somatic hypersensitivity in this patient population. Several investigators have found no evidence for heightened somatic pain sensitivity in IBS patients. Also, others have reported similar cold presser pain tolerance in IBS patients and controls. These conflicting findings may result from differing somatic pain testing procedures. Previous studies have explored the correlates of...

MEBANE, N.C., June 1 /PRNewswire/ -- Behavioral Health Associates of NC, Inc. announces the release for sale of the iPhone symptom tracker application for Irritable Bowel Syndrome. This application helps users keep track of bowel function as well as ten other variables in order to create an accurate picture of IBS symptom experience. The application prepares 24 hour, one week and 90 day graphs of symptoms and can e-mail these graphs along with a text summary to any e-mail address of the...

-- Data Presented Today at DDW Demonstrate Linaclotide Provided Early Onset of Abdominal Pain Relief and Improved Bowel Habits -- CAMBRIDGE, Mass. and NEW YORK, May 31, 2009 /PRNewswire-FirstCall/ -- Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced results from additional analyses of their Phase 2b study assessing the safety and efficacy of the novel, first-in-class agent linaclotide in 419 patients with irritable bowel syndrome with constipation...

IBS Signs and Symptoms Tracker Sheds Light on IBS Warning Signs; IBS Treatment Matrix Helps Patients Find Relief BETHESDA, Md., May 29 /PRNewswire-USNewswire/ -- To mark World Digestive Health Day, the American College of Gastroenterology (ACG), in conjunction with global observances of this awareness day under the auspices of the World Gastroenterology Organisation (WGO), today announced the availability of two new interactive tools aimed at helping to provide answers and hope to millions...

Study Adds to Growing Evidence of B. Infantis 35624 Efficacy in IBS Population CINCINNATI, March 23 /PRNewswire-FirstCall/ -- A review by researchers at Northwestern University (Chicago, IL) and University of Michigan (Ann Arbor, MI) of the utility of probiotics in the treatment of Irritable Bowel Syndrome (IBS) found that Bifidobacterium infantis 35624 was the only probiotic strain out of 13 different individual strains or preparations reviewed to significantly improve symptoms of IBS,...

SAN DIEGO, March 16 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today that it has received New York State approval for PROMETHEUS(R) IBS Diagnostic, the first and only blood test for irritable bowel syndrome (IBS). This novel test incorporates 10 biomarkers, two of which are proprietary, along with a proprietary algorithm to help physicians diagnose patients with IBS. "One out of five Americans has symptoms of IBS, however the...

Chronic gastrointestinal symptoms are highly prevalent in different geographic populations and cause various gastrointestinal symptoms that greatly inconvenience the lives of those affected. Examples include GERD, uninvestigated dyspepsia, irritable bowel syndrome, and chronic constipation. These problems have an impact on the individual's quality of life. There is a lack of community-based research evaluating the impact of chronic gastrointestinal symptoms on the quality of life.A research...